These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32807845)

  • 21. Age-dependent effects of oxytocin in brain regions enriched with oxytocin receptors.
    Xiao S; Ebner NC; Manzouri A; Li TQ; Cortes DS; Månsson KNT; Fischer H
    Psychoneuroendocrinology; 2024 Feb; 160():106666. PubMed ID: 37951085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-Specific Effects of Stress on Oxytocin Neurons Correspond With Responses to Intranasal Oxytocin.
    Steinman MQ; Duque-Wilckens N; Greenberg GD; Hao R; Campi KL; Laredo SA; Laman-Maharg A; Manning CE; Doig IE; Lopez EM; Walch K; Bales KL; Trainor BC
    Biol Psychiatry; 2016 Sep; 80(5):406-14. PubMed ID: 26620251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism.
    Mayer AV; Wermter AK; Stroth S; Alter P; Haberhausen M; Stehr T; Paulus FM; Krach S; Kamp-Becker I
    Sci Rep; 2021 Jul; 11(1):15056. PubMed ID: 34301983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
    Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting non-significant effects of intranasal oxytocin using equivalence testing.
    Quintana DS
    Psychoneuroendocrinology; 2018 Jan; 87():127-130. PubMed ID: 29065361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronically exogenous oxytocin on ovary and uterus: A comparison of intraperitoneal and intranasal administration.
    Senturk GE; Sezer Z; Sahin H; Isildar B; Abdulova A
    Peptides; 2023 Jul; 165():171006. PubMed ID: 37003476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic intranasal oxytocin reverses stress-induced social avoidance in female prairie voles.
    Hale LH; Tickerhoof MC; Smith AS
    Neuropharmacology; 2021 Oct; 198():108770. PubMed ID: 34461067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial.
    Tabak BA; Teed AR; Castle E; Dutcher JM; Meyer ML; Bryan R; Irwin MR; Lieberman MD; Eisenberger NI
    Psychoneuroendocrinology; 2019 Sep; 107():124-132. PubMed ID: 31128568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.
    Song Z; Albers HE
    Front Neuroendocrinol; 2018 Oct; 51():14-24. PubMed ID: 29054552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory.
    Lane A; Luminet O; Nave G; Mikolajczak M
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26991328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulating social behavior with oxytocin: how does it work? What does it mean?
    Churchland PS; Winkielman P
    Horm Behav; 2012 Mar; 61(3):392-9. PubMed ID: 22197271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection.
    Alvares GA; Hickie IB; Guastella AJ
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):316-21. PubMed ID: 20695687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiaggressive activity of central oxytocin in male rats.
    Calcagnoli F; de Boer SF; Althaus M; den Boer JA; Koolhaas JM
    Psychopharmacology (Berl); 2013 Oct; 229(4):639-51. PubMed ID: 23624810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How Can Intranasal Oxytocin Research Be Trusted? A Systematic Review of the Interactive Effects of Intranasal Oxytocin on Psychosocial Outcomes.
    Mierop A; Mikolajczak M; Stahl C; Béna J; Luminet O; Lane A; Corneille O
    Perspect Psychol Sci; 2020 Sep; 15(5):1228-1242. PubMed ID: 32633663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term exposure to intranasal oxytocin in a mouse autism model.
    Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
    Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tri-Phasic Model ofOxytocin (TRIO): A systematic conceptual review of oxytocin-related ERP research.
    Pehlivanoglu D; Myers E; Ebner NC
    Biol Psychol; 2020 Jul; 154():107917. PubMed ID: 32512020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations.
    Wudarczyk OA; Earp BD; Guastella A; Savulescu J
    Curr Opin Psychiatry; 2013 Sep; 26(5):474-484. PubMed ID: 23880593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
    Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
    J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
    Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.